| Document and Entity Information | Mar. 20, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Mar. 20, 2024 |
| Entity File Number | 000-51173 |
| Entity Registrant Name | Gyre Therapeutics, Inc. |
| Entity Central Index Key | 0001124105 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 56-2020050 |
| Entity Address, Address Line One | 12770 High Bluff Drive |
| Entity Address, Address Line Two | Suite 150 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92130 |
| City Area Code | 619 |
| Local Phone Number | 949-3681 |
| Title of 12(b) Security | Common Stock |
| Trading Symbol | GYRE |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
